The 30th Annual Dermatology Nurses’ Association (DNA) Annual Convention was held February 16-19, 2012 in Denver, CO with the theme “Taking Dermatology Nursing to New Heights.”
The Cutaneous Lymphoma Foundation’s Vice President, Marianne Tawa, MSN, RN, ANP, a nurse in the cutaneous oncology department at the Dana-Farber Cancer Institute, and Susan Thornton, cutaneous lymphoma patient and the Foundation’s Management Consultant for Programs and Services, attended the event with over 400 nurses who showed tremendous interest in learning more about cutaneous lymphoma and the Foundation.
The convention’s program provided a diverse menu of courses, topics and educational tracks with two sessions specific to cutaneous T-cell lymphoma (CTCL) presented by Sue McCann, MSN, RN, DNC, University of Pittsburgh Medical Center and close supporter of the Foundation. One of Sue’s presentations was on “Challenging Cases in CTCL,” which provided an in-depth overview of four case studies representing different complexities and treatment therapies along with a variety of outcomes. This presentation was concluded with a discussion on nursing implications of treating CTCL, noting that the patient advocacy organizations can provide important support to patients – with the Cutaneous Lymphoma Foundation at the top of the list.
In addition to attending many of the educational programs, the Foundation participated in activities with the Coalition of Skin Diseases (CSD) of which the Foundation is a member. Manning their exhibit booth for many hours throughout the event provided a high level of visibility and an opportunity to engage with nurses from across the country, promote the Foundation, and discuss ways that they can help their patients through programs offered at the Foundation. At the CSD’s booth, nurses were able to learn more about the new “Skin Advocate iPhone app,” which will help nurses share information with their patients about skin patient advocacy organizations featured in the app (click here to learn more about the app).
During the meeting, several new projects were discussed with DNA leadership and the Journal of the Dermatology Nurses’ Association (JDNA). The first is plans for a plenary session at the 2013 meeting that would focus on helping nurses learn more about skin patient advocacy organizations. Another is featuring ongoing articles about these organizations, including the Cutaneous Lymphoma Foundation, in the JDNA.
This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.